Home
About Us
About Us
Board of Directors
Scientific Advisory Board
Management Team
Careers
For Researchers
Paxalisib
EVT801
Collaborating with Kazia
Publications and Presentations
For Partners
Our Current Partners
What We Are Looking For
For Patients
Accessing Kazia Drug Candidates in Clinical Trials
Accessing Kazia Drug Candidates for Compassionate Use
Resources for Patients
For Investors
ASX Announcements
SEC Filings
Corporate Presentations
Annual Reports
Financial Reports
AGM
Investor Newsletters
Corporate Governance
Shareholder Services
Media Centre
Overview
Latest News
Video
Coverage
Contact
Contact Us
Subscribe to email alerts
Heading &
Sub-heading can be edited through HQI
Home
>
Media Centre
>
Latest News
Overview
Latest News
Video
Coverage
Latest News
Filter by Year:
2023
2022
2021
2020
8-Apr-2022
Kazia presents on EVT801 at AACR
21-Mar-2022
Kazia to present at two conferences
28-Feb-2022
First patient into Cornell keto study
31-Jan-2022
Quarterly Activities Report And Appendix 4c
19-Jan-2022
Kazia Corporate Presentation
7-Jan-2022
Kazia Therapeutics To Present At Hc Wainwright Bioconnect Conference
13-Dec-2021
Kazia Therapeutics Appoints Karen Krumeich As Chief Financial Officer
3-Dec-2021
Kazia Announces Positive Final Data From Phase Ii Clinical Study Of Paxalisib In Newly Diagnosed Glioblastoma
29-Nov-2021
Gbm Agile Opens To Paxalisib In Canada
15-Nov-2021
Kazia Therapeutics Appoints John Friend, Md, As Chief Medical Officer
Previous
1
2
3
4
5
Next
